Ex Parte SJAARDA - Page 14




                   Appeal No. 2001-2073                                                                                                                                   
                   Application No. 09/098,799                                                                                                                             


                   novelty is the ultimate or epitome of obviousness.  See, for                                                                                           
                   example, In re Fracalossi, 681 F.2d 792, 794, 215 USPQ 569, 571                                                                                        
                   (CCPA 1982); In re Pearson, 494 F.2d 1399, 1402,  181 USPQ 641,                                                                                        
                   644 (CCPA 1974).                                                                                                                                       


                   As for claim 7 and the requirement therein that the                                                                                                    
                   longitudinal bore of the housing be "smaller than fifteen (15)                                                                                         
                   gauge in diameter," we agree with appellant's arguments on pages                                                                                       
                   15-18 of the brief that there is no reasonable basis to modify                                                                                         
                   the housing (A) of the vaginal syringe of Graham to be smaller                                                                                         
                   than fifteen gauge, and that if such a modification were made,                                                                                         
                   the vaginal syringe of Graham would be unusable for its intended                                                                                       
                   purpose.  Thus, we will not sustain the examiner's rejection of                                                                                        
                   claim 7 under 35 U.S.C. § 103 based on Graham.                                                                                                         


                   In summary: we have                                                                                                                                    


                   1) reversed the examiner's rejection of claim 6 under                                                                                                  
                   35 U.S.C. § 112, first paragraph;                                                                                                                      


                   2) reversed the rejection of claims 1 through 10 under                                                                                                 
                   35 U.S.C. § 112, second paragraph;                                                                                                                     

                                                                                   1414                                                                                   





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007